EZETIMIB STADA

Main information

  • Trade name:
  • EZETIMIB STADA Tablet 10MG
  • Dosage:
  • 10MG
  • Pharmaceutical form:
  • Tablet
  • Administration route:
  • Oral use
  • Units in package:
  • 90 Blister
  • Prescription type:
  • with prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EZETIMIB STADA Tablet 10MG
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • EZETIMIBE
  • Product summary:
  • EZETIMIB STADA

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • R - active MA/authorised medicinal product
  • Authorization number:
  • 31/ 389/16-C
  • Last update:
  • 16-01-2018

10-9-2018

Silapo (STADA Arzneimittel AG)

Silapo (STADA Arzneimittel AG)

Silapo (Active substance: epoetin zeta) - Centralised - Yearly update - Commission Decision (2018)5944 of Mon, 10 Sep 2018

Europe -DG Health and Food Safety